Security Snapshot

Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TCNNF) Institutional Ownership

CUSIP: 89788C104

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

5

Shares (Excl. Options)

185,304

Price

$5.60

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+31,801
Value change
+$176,819
Number of holders
5
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
168,103,448
SEC-reported price per share
$8.52
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TCNNF - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value is tracked under CUSIP 89788C104.
  • 5 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 7 to 5 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,334,814 to $1,037,923.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 5 institutions filings for Q1 2026.

Open SEC evidence

Security key

89788C104

Latest holder period

Q1 2026

13F holders

5

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
TCNNF
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Marex Securities Products Inc. 5.8% $51,675,000 9,750,000 Marex Securities Products Inc. 16 Dec 2025

As of 31 Mar 2026, 5 institutional investors reported holding 185,304 shares of Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TCNNF). This represents 0.11% of the company’s total 168,103,448 outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
32
Latest
Q1 2026
Rows shown
1-25 of 32
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 185,304 $1,037,923 +$176,819 $5.60 5
2025 Q4 153,603 $1,334,814 -$101,646 $8.69 7
2025 Q3 53,669 $432,747 +$8,060 $8.06 7
2025 Q2 52,669 $200,245 +$1,482 $3.80 7
2025 Q1 52,279 $201,755 -$4,348 $3.86 6
2024 Q4 53,379 $277,327 -$10,457 $5.18 7
2024 Q3 48,323 $588,415 -$108,570 $12.20 7
2024 Q2 57,208 $529,093 +$78,104 $9.25 6
2024 Q1 48,725 $604,270 -$95,304 $12.47 4
2023 Q4 56,530 $294,126 -$165,277 $5.21 5
2023 Q3 82,111 $500,513 +$88,809 $6.09 7
2023 Q2 67,581 $264,944 -$275,506 $3.93 8
2023 Q1 111,664 $632,640 +$209,473 $5.59 10
2022 Q4 89,995 $682,647 -$155,867 $7.60 10
2022 Q3 101,903 $867,476 -$1,934,643 $8.51 8
2022 Q2 268,111 $3,093,000 -$287,442 $11.49 12
2022 Q1 288,838 $14,552,000 +$2,807,181 $21.05 12
2021 Q4 350,882 $9,128,546 +$6,241,814 $26.02 15
2021 Q3 100,046 $2,694,095 +$83,467 $26.93 10
2021 Q2 96,442 $3,618,998 +$35,205 $37.62 8
2021 Q1 91,480 $4,164,729 -$3,444,751 $45.54 13
2020 Q4 198,403 $6,269,391 +$1,876,283 $31.62 10
2020 Q3 171,660 $3,176,000 +$1,458,187 $18.50 9
2020 Q2 93,006 $1,168,000 +$52,830 $12.56 9
2020 Q1 88,858 $814,000 -$1,574,597 $9.16 7
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .